Identification of m6A suppressor EIF4A3 as a novel cancer prognostic and immunotherapy biomarker through bladder cancer clinical data validation and pan-cancer analysis

EIF4A3 represents a novel m6A suppressor that exerts control over the global m6A mRNA modification level, therefore influencing gene destiny. Despite increasing evidence that highlights a pivotal role of EIF4A3 in tumor progression and immunity, a comprehensive pan-cancer analysis of EIF4A3 has yet...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Huaqing, Zhang, Liqi, Li, Rubing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542776/
https://www.ncbi.nlm.nih.gov/pubmed/37777564
http://dx.doi.org/10.1038/s41598-023-43500-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542776/
https://www.ncbi.nlm.nih.gov/pubmed/37777564
http://dx.doi.org/10.1038/s41598-023-43500-4

Ejemplares similares